C-reactive protein (CRP), one of the inflammatory markers, was found its up-regulation was associated with poor prognosis in small cell lung cancer, osteosarcoma, prostate cancer and colorectal cancer [13–16]. This evidence concerns the gene CRP and prostate cancer.